-
AMT-130 at Four Years: Hopeful Signs, Complex Controls
12 min read
Latest News
-
September 2026: This month in Huntington’s disease research
5 min read
September brought progress across the HD research landscape. From brain waves and visual thinking to DNA repeats, nutrition, inclusive care, new technologies, and encouraging SKY-0515 data, we round up a busy month in Huntington’s disease research.
-
Safety trials add crucial piece to gene silencing jigsaw
10 min read
Three trials of drugs to 'silence' the HD gene in monkeys show they hit the target safely. Human trials coming soon.
-
Melatonin treatment success in HD mice
9 min read
Melatonin delays disease onset and extends survival in Huntington's disease mice – could it do the same for patients?
-
HD World Congress 2011: a retrospective
8 min read
HDBuzz looks back at the highlights of the Huntington's disease world congress 2011 in Melbourne
-
HDAC inhibitors and a possible 'blood biomarker'
9 min read
HDAC inhibitors explained, plus how new HDAC-related Huntington's disease research might help us find biomarkers
-
HD just got cilia
5 min read
Huntington's disease just got cilia: huntingtin protein affects tiny but important hairs on cells called cilia
-
Gene silencing takes a targeted step forward
6 min read
Targeting the mutant Huntington's disease gene for silencing, while leaving the healthy gene untouched
-
Prana Biotech's new trial of PBT2 in Huntington's disease: the lowdown
7 min read
Prana Biotech's PBT2 trial in Huntington's disease: what we know so far & what copper has to do with the mutant prote
-
Oz Buzz Video: Day 2
25 min read
The final day of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-
Oz Buzz Video: Day 1
32 min read
Day 1 of Oz Buzz: the nightly news, interviews and features presentation from the HD World Congress 2011
-
Oz Buzz Updates: Day 3
5 min read
Day 3 of our coverage of the Huntington's disease World Congress 2011 in Melbourne
HDBuzz Trial Tracker
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
